Skip to content

Achieve Life Sciences ACHV Retained Earnings

Retained Earnings at other companies

Pfizer logo
PfizerPFE
$117.24B-2.0%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-$283.13M-43.3%
Philip Morris International logo
Philip Morris InternationalPM
$35.54B+6.3%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's retained earnings?
Achieve Life Sciences (ACHV) reported retained earnings of -$270.39M in Q1 2026.
How has Achieve Life Sciences's retained earnings changed year-over-year?
Achieve Life Sciences's retained earnings decreased by 23.8% year-over-year, from -$218.41M to -$270.39M.
What is the long-term trend for Achieve Life Sciences's retained earnings?
Over 5 years (2020 to 2025), Achieve Life Sciences's retained earnings has grown at a 33.9% compound annual growth rate (CAGR), from -$60.43M to -$260.23M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.